No
share options were granted, forfeited or exercised during the six months ended 30 June 2026. The expense for the period of €233k
relates to the options granted to employees and directors in 2025, which vest quarterly with service.
Schedule
of share options
| | |
Number of
options | | |
Weighted
average
exercise price | | |
Weighted
average grant
date fair value | |
| Outstanding at 1 January 2026 | |
| 896,385 | | |
$ | 11.47 | | |
$ | 7.49 | |
| Granted during the period | |
| - | | |
| | | |
| | |
| Forfeited during the period | |
| - | | |
| | | |
| | |
| Exercised during the period | |
| - | | |
| | | |
| | |
| Outstanding at 30 June 2026 | |
| 896,385 | | |
$ | 11.47 | | |
$ | 7.49 | |
| Exercisable at 30 June 2026 | |
| 312,573 | | |
| | | |
| | |
|